NPI: 1417924929 · CORAL SPRINGS, FL 33065 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/02/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/02/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 12,066 | $2.05M |
| 2019 | 19,304 | $2.30M |
| 2020 | 23,168 | $3.48M |
| 2021 | 18,221 | $1.01M |
| 2022 | 10,515 | $1.66M |
| 2023 | 1,731 | $315K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 31,307 | 1,202 | $3.91M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 23,413 | 1,480 | $3.43M |
| J1270 | Injection, doxercalciferol, 1 mcg | 13,383 | 765 | $1.45M |
| A4657 | Syringe, with or without needle, each | 3,038 | 1,214 | $543K |
| J1756 | Injection, iron sucrose, 1 mg | 5,226 | 861 | $469K |
| 85041 | 1,542 | 882 | $166K | |
| 82728 | 1,398 | 868 | $166K | |
| 85048 | 1,518 | 867 | $163K | |
| 83540 | 1,373 | 857 | $162K | |
| 83550 | 1,381 | 860 | $162K | |
| 83970 | 866 | 537 | $117K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 244 | 62 | $37K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 232 | 141 | $23K |
| 82108 | 84 | 58 | $11K |